Details for 2016828511

Up to date per 03.04.2026

Actions

Title / Product Name

MIT DER ANTWORT AUF CRTH2-REZEPTOR-ANTAGONISTEN ASSOZIIERTE GENETISCHE MARKER

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016828511

EP Publication Number

3337803

E-Number

1511721

Language

PCT Number

US16043234

Publication Date

27.06.2018 A

17.08.2022 B1

Registration Date

17.08.2022

AT Publication Date

15.09.2022

Application Date

21.07.2016

Registration Number

Priorities

23.07.2015

201562196128 P

IPC

A61K 31/437 20060101AFI20190306BHEP

Maximum Duration of Protection

21.07.2036

Owner

Merck Sharp & Dohme LLC126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

Representative

No representatives present

Inventor

OPITECK, Gregory, J.5080 Caminito Exquisito San Diego, California 92130US

WONG, Peggy, H.126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

MCELWEE, Joshua33 Avenue Louis Pasteur Boston, Massachusetts 02115-5727US

MEHROTRA, Devan, V.351 N. Sumneytown Pike North Wales, Pennsylvania 19454US

GREENBERG, Steven1 Health Plaza East Hanover, New Jersey 07936US

GUO, Zifang351 N. Sumneytown Pike North Wales, Pennsylvania 19454US